Key Highlights
- Oscar Health shares closed down 11.86% on August 6 at $26.54
- Q2 adjusted EPS of $1.10 beat the $0.43 estimate, and revenue of $4.98 billion beat the $4.78 billion estimate
- Q2 net income reached $362 million, up sharply year over year, with adjusted EBITDA of $415 million
- Medical loss ratio improved nearly 12 points year over year to 79.2%
- The company raised full-year 2026 earnings from operations guidance to $500 to $700 million
What Happened
Oscar Health (NYSE:OSCR) shares closed down 11.86% on August 6 at $26.54, despite the health insurer reporting record first-half 2026 profitability. Oscar Health is a technology-driven health insurance company headquartered in New York City, primarily serving individuals and families through Affordable Care Act marketplace plans, as well as small group employer coverage, differentiating itself through a proprietary technology platform that supports member engagement, care navigation, and administrative services.
Q2 revenue grew 70% year over year to $4.9 billion, driven by 46% membership growth to 2.96 million members. Adjusted EPS of $1.10 beat the $0.43 estimate, with Q2 net income of $362 million, up sharply from the prior year, and adjusted EBITDA of $415 million. Medical loss ratio improved nearly 12 points year over year to 79.2%, and the SG&A ratio hit a record low of 14.2%, down 450 basis points year over year.
Guidance Raised, But Second-Half Concerns Weigh
The company raised full-year 2026 guidance, with earnings from operations now expected at $500 to $700 million, up $250 million from the prior outlook, and improved medical loss ratio guidance of 81.5% to 82.5%. Management also cited favorable 2025 risk adjustment true-up of roughly $160 million and favorable prior period development of $232 million year to date as tailwinds not fully reflected in guidance.
Despite the improved outlook, the stock reversed an early spike of more than 20% in pre-market trading and closed lower as investors focused on the company's expectation of accelerated membership churn in the second half of 2026, roughly double the prior monthly assumption, tied to CMS premium integrity and eligibility verification efforts. Management described the churn as a timing issue already reflected in guidance and not expected to impact revenue, with further long-term growth strategy detail expected at the company's Investor Day on September 16.
Conclusion
Oscar Health's close down 11.86% on August 6, despite record first-half profitability and raised guidance, illustrates how sensitive investors remain to any signs of membership or medical cost pressure in the ACA marketplace segment.
This article is for informational purposes only and does not constitute financial or investment advice. Readers should conduct their own research or consult a financial professional before making investment decisions.






Please wait processing your request...